| Year |
Citation |
Score |
| 2017 |
Nathan S, Ma Y, Tomita YA, De Oliveira E, Brown ML, Rosen EM. BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells. Breast Cancer Research and Treatment. PMID 28808806 DOI: 10.1007/S10549-017-4442-Y |
0.406 |
|
| 2017 |
Nathan S, Rosen EM. Abstract 3602: Novel BRCA1 mimetic 35446HCl inhibits growth of anti estrogen resistant breast cancer cells through the NF-κB pathway Cancer Research. 77: 3602-3602. DOI: 10.1158/1538-7445.Am2017-3602 |
0.442 |
|
| 2015 |
Ma Y, Preet A, Tomita Y, De Oliveira E, Zhang L, Ueda Y, Clarke R, Brown M, Rosen EM. A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance. Oncotarget. PMID 26575173 DOI: 10.18632/Oncotarget.6323 |
0.362 |
|
| 2014 |
Ma Y, Tomita Y, Preet A, Clarke R, Englund E, Grindrod S, Nathan S, De Oliveira E, Brown ML, Rosen EM. Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-α. Molecular Endocrinology (Baltimore, Md.). 28: 1971-86. PMID 25264941 DOI: 10.1210/Me.2014-1146 |
0.347 |
|
| 2014 |
Rosen EM, Pishvaian MJ. Targeting the BRCA1/2 tumor suppressors. Current Drug Targets. 15: 17-31. PMID 24387337 |
0.368 |
|
| 2013 |
Xu JY, Meng QH, Chong Y, Jiao Y, Zhao L, Rosen EM, Fan S. Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration. Molecular and Clinical Oncology. 1: 331-336. PMID 24649171 DOI: 10.3892/Mco.2012.41 |
0.349 |
|
| 2013 |
Fan S, Meng Q, Xu J, Jiao Y, Zhao L, Zhang X, Sarkar FH, Brown ML, Dritschilo A, Rosen EM. DIM (3,3'-diindolylmethane) confers protection against ionizing radiation by a unique mechanism. Proceedings of the National Academy of Sciences of the United States of America. 110: 18650-5. PMID 24127581 DOI: 10.1073/Pnas.1308206110 |
0.302 |
|
| 2013 |
Rosen EM. BRCA1 in the DNA damage response and at telomeres. Frontiers in Genetics. 4: 85. PMID 23802008 DOI: 10.3389/Fgene.2013.00085 |
0.493 |
|
| 2013 |
Ma Y, Preet A, Hu C, Kumar A, Ma J, Tomita Y, Rosen EM. Abstract 5574: Development of novel breast cancer therapeutics for anti-estrogen resistant breast cancer. Cancer Research. 73: 5574-5574. DOI: 10.1158/1538-7445.Am2013-5574 |
0.401 |
|
| 2013 |
Oliveira EOD, Ma Y, Tomita Y, Rosen E, Brown ML. Abstract 2458: Discovery and development of novel 4-aminopyrimidines (A9 analogs) as potential BRCA1-mimetic drugs for the treatment of breast cancer. Cancer Research. 73: 2458-2458. DOI: 10.1158/1538-7445.Am2013-2458 |
0.393 |
|
| 2012 |
Xu JY, Meng QH, Chong Y, Jiao Y, Zhao L, Rosen EM, Fan S. Sanguinarine inhibits growth of human cervical cancer cells through the induction of apoptosis. Oncology Reports. 28: 2264-70. PMID 22965493 DOI: 10.3892/Or.2012.2024 |
0.415 |
|
| 2012 |
Xiao X, Meng Q, Xu J, Jiao Y, Rosen EM, Fan S. [EGFR-dependent impact of indol-3-carbinol on radiosensitivity of lung cancer cells]. Zhongguo Fei Ai Za Zhi = Chinese Journal of Lung Cancer. 15: 391-8. PMID 22814257 DOI: 10.3779/J.Issn.1009-3419.2012.07.01 |
0.312 |
|
| 2012 |
Hyun SY, Rosen EM, Jang YJ. Novel DNA damage checkpoint in mitosis: Mitotic DNA damage induces re-replication without cell division in various cancer cells. Biochemical and Biophysical Research Communications. 423: 593-9. PMID 22704936 DOI: 10.1016/J.Bbrc.2012.06.023 |
0.397 |
|
| 2012 |
Karve TM, Preet A, Sneed R, Salamanca C, Li X, Xu J, Kumar D, Rosen EM, Saha T. BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells. Plos One. 7: e37697. PMID 22685544 DOI: 10.1371/Journal.Pone.0037697 |
0.755 |
|
| 2012 |
Wang LL, Meng QH, Jiao Y, Xu JY, Ge CM, Zhou JY, Rosen EM, Wang HC, Fan SJ. High-mobility group boxes mediate cell proliferation and radiosensitivity via retinoblastoma-interaction-dependent and -independent mechanisms. Cancer Biotherapy & Radiopharmaceuticals. 27: 329-35. PMID 22655796 DOI: 10.1089/Cbr.2012.1199 |
0.389 |
|
| 2012 |
Karve TM, Rosen EM. B-cell translocation gene 2 (BTG2) stimulates cellular antioxidant defenses through the antioxidant transcription factor NFE2L2 in human mammary epithelial cells. The Journal of Biological Chemistry. 287: 31503-14. PMID 22493435 DOI: 10.1074/Jbc.M112.367433 |
0.752 |
|
| 2011 |
Hu XD, Meng QH, Xu JY, Jiao Y, Ge CM, Jacob A, Wang P, Rosen EM, Fan S. BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity. Biochemical and Biophysical Research Communications. 404: 903-9. PMID 21172304 DOI: 10.1016/J.Bbrc.2010.12.064 |
0.366 |
|
| 2011 |
Li X, Meng Q, Rosen EM, Fan S. UHRF1 confers radioresistance to human breast cancer cells. International Journal of Radiation Biology. 87: 263-73. PMID 21067293 DOI: 10.3109/09553002.2011.530335 |
0.432 |
|
| 2010 |
Saha T, Smulson M, Rosen EM. BRCA1 regulation of base excision repair pathway. Cell Cycle (Georgetown, Tex.). 9: 2471-2. PMID 20581465 DOI: 10.4161/Cc.9.13.12084 |
0.399 |
|
| 2010 |
Saha T, Rih JK, Roy R, Ballal R, Rosen EM. Transcriptional regulation of the base excision repair pathway by BRCA1. The Journal of Biological Chemistry. 285: 19092-105. PMID 20185827 DOI: 10.1074/Jbc.M110.104430 |
0.788 |
|
| 2010 |
Fan S, Meng Q, Laterra JJ, Rosen EM. Scatter factor protects tumor cells against apoptosis caused by TRAIL. Anti-Cancer Drugs. 21: 10-24. PMID 19823077 DOI: 10.1097/Cad.0B013E32832Afc3B |
0.365 |
|
| 2010 |
Karve TM, Fan S, Rosen EM. Abstract 1119: Role of BTG2 in the antioxidant response in breast cancer cells Cancer Research. 70: 1119-1119. DOI: 10.1158/1538-7445.Am10-1119 |
0.763 |
|
| 2009 |
Ballal RD, Saha T, Fan S, Haddad BR, Rosen EM. BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage. The Journal of Biological Chemistry. 284: 36083-98. PMID 19797051 DOI: 10.1074/Jbc.M109.025825 |
0.762 |
|
| 2009 |
Ballal R, Cheema A, Ahmad W, Rosen EM, Saha T. Fluorescent oligonucleotides can serve as suitable alternatives to radiolabeled oligonucleotides. Journal of Biomolecular Techniques : Jbt. 20: 190-4. PMID 19721820 |
0.73 |
|
| 2009 |
Li Y, Rory Goodwin C, Sang Y, Rosen EM, Laterra J, Xia S. Camptothecin and Fas receptor agonists synergistically induce medulloblastoma cell death: ROS-dependent mechanisms. Anti-Cancer Drugs. 20: 770-8. PMID 19633536 DOI: 10.1097/Cad.0B013E32832Fe472 |
0.305 |
|
| 2009 |
Fan S, Meng Q, Saha T, Sarkar FH, Rosen EM. Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner. Cancer Research. 69: 6083-91. PMID 19622773 DOI: 10.1158/0008-5472.Can-08-3309 |
0.383 |
|
| 2009 |
Katiyar P, Ma Y, Riegel A, Fan S, Rosen EM. Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity. Molecular Endocrinology (Baltimore, Md.). 23: 1135-46. PMID 19389812 DOI: 10.1210/me.2008-0347 |
0.33 |
|
| 2009 |
Saha T, Rih JK, Rosen EM. BRCA1 down-regulates cellular levels of reactive oxygen species. Febs Letters. 583: 1535-43. PMID 19364506 DOI: 10.1016/J.Febslet.2009.04.005 |
0.46 |
|
| 2009 |
Veras I, Rosen EM, Schramm L. Inhibition of RNA polymerase III transcription by BRCA1. Journal of Molecular Biology. 387: 523-31. PMID 19361418 DOI: 10.1016/J.Jmb.2009.02.008 |
0.351 |
|
| 2009 |
Hong YB, Kang HJ, Kim HJ, Rosen EM, Dakshanamurthy S, Rondanin R, Baruchello R, Grisolia G, Daniele S, Bae I. Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells. Experimental & Molecular Medicine. 41: 151-60. PMID 19293634 DOI: 10.3858/Emm.2009.41.3.018 |
0.421 |
|
| 2009 |
Fan S, Meng Q, Laterra JJ, Rosen EM. Role of Src signal transduction pathways in scatter factor-mediated cellular protection. The Journal of Biological Chemistry. 284: 7561-77. PMID 19047046 DOI: 10.1074/Jbc.M807497200 |
0.357 |
|
| 2008 |
Eisen A, Lubinski J, Gronwald J, Moller P, Lynch HT, Klijn J, Kim-Sing C, Neuhausen SL, Gilbert L, Ghadirian P, Manoukian S, Rennert G, Friedman E, Isaacs C, Rosen E, et al. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. Journal of the National Cancer Institute. 100: 1361-7. PMID 18812548 DOI: 10.1093/Jnci/Djn313 |
0.361 |
|
| 2008 |
Reznik TE, Sang Y, Ma Y, Abounader R, Rosen EM, Xia S, Laterra J. Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor. Molecular Cancer Research : McR. 6: 139-50. PMID 18234969 DOI: 10.1158/1541-7786.Mcr-07-0236 |
0.333 |
|
| 2008 |
Jones LP, Tilli MT, Assefnia S, Torre K, Halama ED, Parrish A, Rosen EM, Furth PA. Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene. 27: 794-802. PMID 17653086 DOI: 10.1038/Sj.Onc.1210674 |
0.37 |
|
| 2007 |
Xia S, Li Y, Rosen EM, Laterra J. Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim. Molecular Cancer Research : McR. 5: 783-92. PMID 17699104 DOI: 10.1158/1541-7786.Mcr-06-0433 |
0.326 |
|
| 2007 |
Ma Y, Hu C, Riegel AT, Fan S, Rosen EM. Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity. Molecular Endocrinology (Baltimore, Md.). 21: 1905-23. PMID 17505062 DOI: 10.1210/Me.2006-0397 |
0.359 |
|
| 2007 |
Fan S, Meng Q, Laterra JJ, Rosen EM. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage. Oncogene. 26: 4774-96. PMID 17297451 DOI: 10.1038/Sj.Onc.1210271 |
0.322 |
|
| 2007 |
Xu J, Gao M, Fan S, Meng Q, Goldberg ID, Abounader R, Ressom H, Laterra JJ, Rosen EM. Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells. Oncogene. 26: 2925-38. PMID 17099727 DOI: 10.1038/Sj.Onc.1210088 |
0.478 |
|
| 2006 |
Ma Y, Yuan RQ, Fan S, Hu C, Goldberg ID, Laterra JJ, Rosen EM. Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum. Anti-Cancer Drugs. 17: 733-51. PMID 16926624 DOI: 10.1097/01.Cad.0000217429.67455.18 |
0.439 |
|
| 2006 |
Katiyar P, Ma Y, Fan S, Pestell RG, Furth PA, Rosen EM. Regulation of progesterone receptor signaling by BRCA1 in mammary cancer. Nuclear Receptor Signaling. 4: e006. PMID 16741564 DOI: 10.1621/Nrs.04006 |
0.466 |
|
| 2006 |
Kang HJ, Kim HJ, Kim SK, Barouki R, Cho CH, Khanna KK, Rosen EM, Bae I. BRCA1 modulates xenobiotic stress-inducible gene expression by interacting with ARNT in human breast cancer cells. The Journal of Biological Chemistry. 281: 14654-62. PMID 16567799 DOI: 10.1074/Jbc.M601613200 |
0.496 |
|
| 2006 |
Fan S, Meng Q, Auborn K, Carter T, Rosen EM. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. British Journal of Cancer. 94: 407-26. PMID 16434996 DOI: 10.1038/sj.bjc.6602935 |
0.359 |
|
| 2006 |
Ma Y, Katiyar P, Jones LP, Fan S, Zhang Y, Furth PA, Rosen EM. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. Molecular Endocrinology (Baltimore, Md.). 20: 14-34. PMID 16109739 DOI: 10.1210/Me.2004-0488 |
0.5 |
|
| 2006 |
Rosen EM, Fan S, Ma Y. BRCA1 regulation of transcription. Cancer Letters. 236: 175-85. PMID 15975711 DOI: 10.1016/J.Canlet.2005.04.037 |
0.466 |
|
| 2005 |
Bae I, Rih JK, Kim HJ, Kang HJ, Haddad B, Kirilyuk A, Fan S, Avantaggiati ML, Rosen EM. BRCA1 regulates gene expression for orderly mitotic progression. Cell Cycle (Georgetown, Tex.). 4: 1641-66. PMID 16258266 DOI: 10.4161/Cc.4.11.2152 |
0.515 |
|
| 2005 |
Rosen EM, Fan S, Isaacs C. BRCA1 in hormonal carcinogenesis: basic and clinical research. Endocrine-Related Cancer. 12: 533-48. PMID 16172191 DOI: 10.1677/erc.1.00972 |
0.385 |
|
| 2005 |
Wang C, Fan S, Li Z, Fu M, Rao M, Ma Y, Lisanti MP, Albanese C, Katzenellenbogen BS, Kushner PJ, Weber B, Rosen EM, Pestell RG. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity. Cancer Research. 65: 6557-67. PMID 16061635 DOI: 10.1158/0008-5472.Can-05-0486 |
0.426 |
|
| 2005 |
Zhang Y, Fan S, Meng Q, Ma Y, Katiyar P, Schlegel R, Rosen EM. BRCA1 interaction with human papillomavirus oncoproteins. The Journal of Biological Chemistry. 280: 33165-77. PMID 15983032 DOI: 10.1074/Jbc.M505124200 |
0.365 |
|
| 2005 |
Xia S, Rosen EM, Laterra J. Sensitization of glioma cells to Fas-dependent apoptosis by chemotherapy-induced oxidative stress. Cancer Research. 65: 5248-55. PMID 15958570 DOI: 10.1158/0008-5472.Can-04-4332 |
0.323 |
|
| 2005 |
Jones LP, Li M, Halama ED, Ma Y, Lubet R, Grubbs CJ, Deng CX, Rosen EM, Furth PA. Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer. Oncogene. 24: 3554-62. PMID 15750629 DOI: 10.1038/Sj.Onc.1208426 |
0.459 |
|
| 2005 |
Fan S, Gao M, Meng Q, Laterra JJ, Symons MH, Coniglio S, Pestell RG, Goldberg ID, Rosen EM. Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene. 24: 1749-66. PMID 15688034 DOI: 10.1038/Sj.Onc.1208327 |
0.369 |
|
| 2005 |
Xu J, Fan S, Rosen EM. Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1. Endocrinology. 146: 2031-47. PMID 15637295 DOI: 10.1210/En.2004-0409 |
0.435 |
|
| 2004 |
Bae I, Fan S, Meng Q, Rih JK, Kim HJ, Kang HJ, Xu J, Goldberg ID, Jaiswal AK, Rosen EM. BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Research. 64: 7893-909. PMID 15520196 DOI: 10.1158/0008-5472.Can-04-1119 |
0.526 |
|
| 2004 |
Abounader R, Reznik T, Colantuoni C, Martinez-Murillo F, Rosen EM, Laterra J. Regulation of c-Met-dependent gene expression by PTEN. Oncogene. 23: 9173-82. PMID 15516982 DOI: 10.1038/Sj.Onc.1208146 |
0.41 |
|
| 2004 |
Razandi M, Pedram A, Rosen EM, Levin ER. BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Molecular and Cellular Biology. 24: 5900-13. PMID 15199145 DOI: 10.1128/Mcb.24.13.5900-5913.2004 |
0.474 |
|
| 2003 |
Xiong J, Fan S, Meng Q, Schramm L, Wang C, Bouzahza B, Zhou J, Zafonte B, Goldberg ID, Haddad BR, Pestell RG, Rosen EM. BRCA1 inhibition of telomerase activity in cultured cells. Molecular and Cellular Biology. 23: 8668-90. PMID 14612409 DOI: 10.1128/Mcb.23.23.8668-8690.2003 |
0.491 |
|
| 2003 |
Fu M, Rao M, Wang C, Sakamaki T, Wang J, Di Vizio D, Zhang X, Albanese C, Balk S, Chang C, Fan S, Rosen E, Palvimo JJ, Jänne OA, Muratoglu S, et al. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Molecular and Cellular Biology. 23: 8563-75. PMID 14612401 DOI: 10.1128/Mcb.23.23.8563-8575.2003 |
0.347 |
|
| 2003 |
Rosen EM, Fan S, Pestell RG, Goldberg ID. BRCA1 in hormone-responsive cancers. Trends in Endocrinology and Metabolism: Tem. 14: 378-85. PMID 14516936 DOI: 10.1016/j.tem.2003.08.001 |
0.392 |
|
| 2003 |
Auborn KJ, Fan S, Rosen EM, Goodwin L, Chandraskaren A, Williams DE, Chen D, Carter TH. Indole-3-carbinol is a negative regulator of estrogen. The Journal of Nutrition. 133: 2470S-2475S. PMID 12840226 DOI: 10.1093/Jn/133.7.2470S |
0.324 |
|
| 2003 |
Rosen EM, Fan S, Pestell RG, Goldberg ID. BRCA1 gene in breast cancer. Journal of Cellular Physiology. 196: 19-41. PMID 12767038 DOI: 10.1002/Jcp.10257 |
0.525 |
|
| 2003 |
Xian Ma Y, Fan S, Xiong J, Yuan RQ, Meng Q, Gao M, Goldberg ID, Fuqua SA, Pestell RG, Rosen EM. Role of BRCA1 in heat shock response. Oncogene. 22: 10-27. PMID 12527903 DOI: 10.1038/Sj.Onc.1206061 |
0.338 |
|
| 2002 |
Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM. p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Research. 62: 141-51. PMID 11782371 |
0.306 |
|
| 2002 |
Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 108-10. PMID 11729097 DOI: 10.1096/Fj.01-0421Fje |
0.352 |
|
| 2001 |
Meng QH, Yuan RQ, Goldberg ID, Rosen EM, Fan SJ. BRCA1 is differentially expressed in human tumor cells. Shi Yan Sheng Wu Xue Bao. 34: 55-64. PMID 12549011 |
0.378 |
|
| 2001 |
Fan S, Yuan RQ, Ma YX, Meng Q, Goldberg ID, Rosen EM. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1 Oncogene. 20: 8215-8235. PMID 11781837 DOI: 10.1038/sj.onc.1205033 |
0.423 |
|
| 2001 |
Yuan R, Fan S, Achary M, Stewart DM, Goldberg ID, Rosen EM. Altered gene expression pattern in cultured human breast cancer cells treated with hepatocyte growth factor/scatter factor in the setting of DNA damage Cancer Research. 61: 8022-8031. PMID 11691828 |
0.445 |
|
| 2001 |
Fan S, Yuan RQ, Ma YX, Xiong J, Meng Q, Erdos M, Zhao JN, Goldberg ID, Pestell RG, Rosen EM. Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding Oncogene. 20: 4827-4841. PMID 11521194 DOI: 10.1038/Sj.Onc.1204666 |
0.43 |
|
| 2001 |
Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity Oncogene. 20: 77-87. PMID 11244506 DOI: 10.1038/sj.onc.1204073 |
0.334 |
|
| 2001 |
Gao B, Shen X, Kunos G, Meng Q, Goldberg ID, Rosen EM, Fan S. Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells Febs Letters. 488: 179-184. PMID 11163768 DOI: 10.1016/S0014-5793(00)02430-3 |
0.399 |
|
| 2000 |
Meng Q, Xu J, Goldberg ID, Rosen EM, Greenwald RA, Fan S. Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells. Clinical & Experimental Metastasis. 18: 139-46. PMID 11235989 DOI: 10.1023/A:1006732424102 |
0.472 |
|
| 2000 |
Meng Q, Yuan F, Goldberg ID, Rosen EM, Auborn K, Fan S. Indole-3-carbinol is a negative regulator of estrogen receptor-α signaling in human tumor cells Journal of Nutrition. 130: 2927-2931. PMID 11110848 DOI: 10.1093/Jn/130.12.2927 |
0.398 |
|
| 2000 |
Meng Q, Goldberg ID, Rosen EM, Fan S. Inhibitory effects of indole-3-carbinol on invasion and migration in human breast cancer cells Breast Cancer Research and Treatment. 63: 147-152. PMID 11097090 DOI: 10.1023/A:1006495824158 |
0.468 |
|
| 2000 |
Meng Q, Mason JM, Porti D, Goldberg ID, Rosen EM, Fan S. Hepatocyte growth factor decreases sensitivity to chemotherapeutic agents and stimulates cell adhesion, invasion, and migration Biochemical and Biophysical Research Communications. 274: 772-779. PMID 10924353 DOI: 10.1006/bbrc.2000.3199 |
0.304 |
|
| 2000 |
Meng Q, Qi M, Chen DZ, Yuan R, Goldberg ID, Rosen EM, Auborn K, Fan S. Suppression of breast cancer invasion and migration by indole-3- carbinol: Associated with up-regulation of BRCA1 and E-cadherin/catenin complexes Journal of Molecular Medicine. 78: 155-165. PMID 10868478 DOI: 10.1007/S001090000088 |
0.319 |
|
| 2000 |
Fan S, Ma YX, Wang JA, Yuan RQ, Meng Q, Cao Y, Laterra JJ, Goldberg ID, Rosen EM. The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase Oncogene. 19: 2212-2223. PMID 10822371 |
0.339 |
|
| 2000 |
Ma Y, Yuan R, Meng Q, Goldberg ID, Rosen EM, Fan S. p53-independent Down-regulation of Mdm2 in human cancer cells treated with adriamycin Molecular Cell Biology Research Communications. 3: 122-128. PMID 10775510 DOI: 10.1006/mcbr.2000.0201 |
0.36 |
|
| 1999 |
Yuan R, Fan S, Wang JA, Meng Q, Ma Y, Schreiber D, Goldberg ID, Rosen EM. Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells Prostate. 40: 37-49. PMID 10344722 DOI: 10.1002/(SICI)1097-0045(19990615)40:1<37::AID-PROS5>3.0.CO;2-P |
0.348 |
|
| 1999 |
Fan S, Wang JA, Yuan R, Ma Y, Meng Q, Erdos MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID, Rosen EM. BRCA1 inhibition of estrogen receptor signaling in transfected cells Science. 284: 1354-1356. PMID 10334989 DOI: 10.1126/Science.284.5418.1354 |
0.376 |
|
| 1999 |
Wang JA, Fan S, Yuan RQ, Ma YX, Meng Q, Goldberg ID, Rosen EM. Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21(WAF1/CIP1) in human cancer cells independently of p53 International Journal of Radiation Biology. 75: 301-316. PMID 10203181 |
0.349 |
|
| 1998 |
Fan S, Twu NF, Wang JA, Yuan RQ, Andres J, Goldberg ID, Rosen EM. Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation International Journal of Cancer. 77: 600-609. PMID 9679765 DOI: 10.1002/(SICI)1097-0215(19980812)77:4<600::AID-IJC21>3.0.CO;2-8 |
0.429 |
|
| 1998 |
Fan S, Wang JA, Yuan RQ, Rockwell S, Andres J, Zlatapolskiy A, Goldberg ID, Rosen EM. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents Oncogene. 17: 131-141. PMID 9674697 DOI: 10.1038/sj.onc.1201943 |
0.397 |
|
| 1998 |
Fan S, Wang JA, Yuan RQ, Ma YX, Meng Q, Erdos MR, Brody LC, Goldberg ID, Rosen EM. BRCA1 as a potential human prostate tumor suppressor: Modulation of proliferation, damage responses and expression of cell regulatory proteins Oncogene. 16: 3069-3082. PMID 9662340 DOI: 10.1038/Sj.Onc.1202116 |
0.397 |
|
| 1998 |
Andres JL, Fan S, Turkel GJ, Wang JA, Twu NF, Yuan RQ, Lamszus K, Goldberg ID, Rosen EM. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Oncogene. 16: 2229-41. PMID 9619832 DOI: 10.1038/sj.onc.1201752 |
0.395 |
|
| 1997 |
Rosen EM, Lamszus K, Laterra J, Polverini PJ, Rubin JS, Goldberg ID. HGF/SF in angiogenesis. Ciba Foundation Symposium. 212: 215-26; discussion 2. PMID 9524773 DOI: 10.1002/9780470515457.CH14 |
0.347 |
|
| 1997 |
Laterra J, Rosen E, Nam M, Ranganathan S, Fielding K, Johnston P. Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth Biochemical and Biophysical Research Communications. 235: 743-747. PMID 9207232 DOI: 10.1006/Bbrc.1997.6853 |
0.354 |
|
| 1997 |
Wang M, Liu YE, Greene J, Sheng S, Fuchs A, Rosen EM, Shi YE. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4 Oncogene. 14: 2767-2774. PMID 9190892 DOI: 10.1038/Sj.Onc.1201245 |
0.311 |
|
| 1997 |
Zitnik RJ, Zhang J, Kashem MA, Kohno T, Lyons DE, Wright CD, Rosen E, Goldberg I, Hayday AC. The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA. Biochemical and Biophysical Research Communications. 232: 687-97. PMID 9126337 DOI: 10.1006/Bbrc.1997.6358 |
0.325 |
|
| 1997 |
Jin L, Fuchs A, Schnitt SJ, Yao Y, Joseph A, Lamszus K, Park M, Goldberg ID, Rosen EM. Expression of scatter factor and c-met receptor in benign and malignant breast tissue Cancer. 79: 749-760. PMID 9024713 DOI: 10.1002/(Sici)1097-0142(19970215)79:4<749::Aid-Cncr12>3.0.Co;2-# |
0.321 |
|
| 1995 |
Joseph A, Weiss GH, Jin L, Fuchs A, Chowdhury S, O'Shaugnessy P, Goldberg ID, Rosen EM. Expression of scatter factor in human bladder carcinoma. Journal of the National Cancer Institute. 87: 372-7. PMID 7853418 DOI: 10.1093/Jnci/87.5.372 |
0.348 |
|
| 1994 |
Rosen EM, Joseph A, Jin L, Rockwell S, Elias JA, Knesel J, Wines J, McClellan J, Kluger MJ, Goldberg ID, Zitnik R. Regulation of scatter factor production via a soluble inducing factor Journal of Cell Biology. 127: 225-234. PMID 7929565 DOI: 10.1083/Jcb.127.1.225 |
0.326 |
|
| 1992 |
Li Y, Joseph A, Bhargava MM, Rosen EM, Nakamura T, Goldberg I. Effect of scatter factor and hepatocyte growth factor on motility and morphology of mdck cells In Vitro Cellular &Amp; Developmental Biology - Animal. 28: 364-368. PMID 1534555 DOI: 10.1007/Bf02877060 |
0.315 |
|
| Show low-probability matches. |